Vericel (VCEL) Intangibles (2014 - 2026)
Vericel's (VCEL) quarterly Intangibles came in at $5.5 million in Q1 2026, down 10.26% year-on-year from $6.1 million in Q1 2025, and down 2.77% quarter-over-quarter from $5.6 million in Q4 2025.
Vericel (VCEL) Intangibles (2014 - 2026) Analysis & Trends
Vericel has disclosed Intangibles across 8 years of filings, most recently posting $5.5 million for Q1 2026.
- Intangibles for Q1 2026 came in at $5.5 million, down 10.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.5 million (down 10.26% YoY), and the FY2025 annual result was $5.6 million, down 10.0% from the prior year.
- Intangibles came in at $5.5 million for Q1 2026 at Vericel, down from $5.6 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $7.5 million in Q4 2022 to a low of $5.5 million in Q1 2026.
- The 5-year median for Intangibles is $6.5 million (2024), against an average of $6.5 million.
- Across the five-year window, Intangibles decreased 8.33% in 2023 and fell 10.26% in 2026, its largest moves.
- Vericel's Intangibles stood at $7.5 million in 2022, then dropped by 8.33% to $6.9 million in 2023, then decreased by 9.09% to $6.2 million in 2024, then slipped by 10.0% to $5.6 million in 2025, then slipped by 2.77% to $5.5 million in 2026.
- The last three Intangibles figures came in at $5.5 million (Q1 2026), $5.6 million (Q4 2025), and $5.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 5.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.47 Mn |
| Dec 31, 2025 | 5.63 Mn |
| Sep 30, 2025 | 5.78 Mn |
| Jun 30, 2025 | 5.94 Mn |
| Mar 31, 2025 | 6.09 Mn |
| Dec 31, 2024 | 6.25 Mn |
| Sep 30, 2024 | 6.41 Mn |
| Jun 30, 2024 | 6.56 Mn |
| Mar 31, 2024 | 6.72 Mn |
| Dec 31, 2023 | 6.88 Mn |
| Sep 30, 2023 | 7.03 Mn |
| Jun 30, 2023 | 7.19 Mn |
| Mar 31, 2023 | 7.34 Mn |
| Dec 31, 2022 | 7.50 Mn |
| Sep 30, 2016 | 2.71 Mn |
| Jun 30, 2016 | 2.78 Mn |
| Mar 31, 2016 | 2.85 Mn |
| Dec 31, 2015 | 2.92 Mn |
| Sep 30, 2015 | 2.99 Mn |
| Jun 30, 2015 | 3.06 Mn |